Cell Line
MCF-7 ADR; MCF-7/ADR; NCI-ADR-RES; OVCAR-8; NCI/ADR-RES
Organism
human
Tissue/Cell type
adenocarcinoma (breast)
Genetically modified (GenTSV)
Risk group (BioStoffV)
1
Risk assessment
According to ZKBS (https://zag.bvl.bund.de/zelllinien/detail.jsf?id=1275&dswid=2452&dsrid=252)
Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)
source | freezing date | passage no. | cell count per vial | cell culture medium incl. supplements | no. of aliquots | belongs to (full name) | rack/box in N2 tank or -80°° freezer and location (room, address) | comments |
---|---|---|---|---|---|---|---|---|
Charite, AG Pathologie | 06.12.2017 | Passage vom 05.06.2012 | DMEM HG 10% FBS 1% P/S +0,05 µg/mL Doxorubicin | 1 | Elisa Quaas/Katharina Achazi | 11/03, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | 、 | |
Charite, AG Pathologie | 16.01.2018 | ? | 1000000 | DMEM HG 10% FBS 1% P/S +0,05 µg/mL Doxorubicin | 3 | Elisa Quaas/Chaitanya Thota | 04/01, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | cells are provided by Prof. Carsten Denkert and Denise Treuert and they need to be cited in resulting publications, it is forbidden to urther distribute the cells to other groups or any other third parties |
Charite, AG Pathologie | 09.01.2018 | p27+7 | 1000000 | DMEM HG 10% FBS 1% P/S +0,05 µg/mL Doxorubicin | 6 | EElisa Quaas/Chaitanya Thota | 04/01, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | cells are provided by Prof. Carsten Denkert and Denise Treuert and they need to be cited in resulting publications, it is forbidden to urther distribute the cells to other groups or any other third parties |
Charite, AG Pathologie | 27.03.2019 | px+5 | 1000000 | DMEM HG 15% FBS 1% P/S +0,05 µg/mL Doxorubicin | 10 | Katharina Achazi/Scarlett Manzke | 03/04, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | cells are provided by Prof. Carsten Denkert and Denise Treuert and they need to be cited in resulting publications, it is forbidden to urther distribute the cells to other groups or any other third parties |